Brighteye Ventures Fund III Reaches $72M First Close

Brighteye Ventures has reached a $72M first close for Fund III, expanding its specialist investment strategy from traditional edtech into the wider systems that shape how people learn, work, and adapt. The September 16, 2026 close brings the firm's company-reported assets under management to $245M.

The distinction between a first close and a final close matters. Brighteye has secured enough capital to begin deploying Fund III, but it has not disclosed the vehicle's target size, final-close timetable, or individual limited-partner commitments. What it has disclosed is a wider thesis: early-stage European technology for learning, productivity, high-stakes professional workflows, talent, managed labor, and labor infrastructure.

What Brighteye Announced

The $72M Fund III first close includes new investors Lumina Foundation, Zanichelli Venture, and PI Impact. They join returning limited partners including the European Investment Fund, Jacobs Foundation, and several unnamed European family offices.

Brighteye says Fund III has already made eight investments and expects to make up to 35 over the coming years. The firm has named imagi, which helps schools build AI fluency; NEX Health Intelligence, which supports infection-control teams in hospitals; and Gyver, a marketplace for electricians tied to Europe's energy-infrastructure workforce, among the vehicle's initial investments.

The firm also says it has invested in more than 50 companies since inception. Those portfolio companies have raised more than $1B in aggregate, according to Brighteye, and multiple companies generate more than $100M in annual revenue. These are company-reported operating metrics, not an independently audited statement of fund returns.

From Edtech to the HumanOS

Brighteye calls its expanded investment frame the HumanOS, shorthand for technology that helps people learn, work, and adapt as software becomes more intelligent. The label is broad, but the disclosed portfolio examples clarify the intended connective tissue: systems that help people build capability, apply knowledge inside a workflow, or enter and move through labor markets.

That moves the firm beyond a conventional education-technology map. An AI-fluency tool for schools, augmented intelligence for hospital infection control, and a marketplace for skilled electricians solve different immediate problems, yet each sits where information has to become human action before it creates value.

The category expansion also raises the standard for specialist judgment. A focused investor can see customer behavior, procurement cycles, talent constraints, and product patterns that a generalist may miss. As the mandate widens, Brighteye will have to show that HumanOS is a repeatable sourcing and portfolio-support advantage rather than a roomy label for whatever AI changes next.

Why the Market Timing Matters

Brighteye's own European Learning & Work Funding Report 2026 says European companies in the category raised €710M in 2024 and €1.6B in 2025. Its H1 2026 update puts first-half funding at €1.4B, roughly 90% of the full-year 2025 total.

The same research describes a market that is growing but increasingly concentrated. Larger rounds are flowing toward companies connected to regulated industries, institutional procurement, workforce transactions, and measurable operating outcomes, while a broader productivity category continues to produce an active early-stage pipeline. Because this dataset comes from Brighteye, it is best read as both market research and an explanation of the opportunities the firm is preparing to fund.

The strategic wager is that AI makes raw intelligence more abundant while increasing the value of judgment, context, skill, and the ability to act inside real organizations. If that holds, learning stops being a separate activity delivered before work and becomes part of the systems through which work gets done.

The Team Behind Fund III

Brighteye's current team is led on investment strategy by founding partners Ben Wirz and Alex Spiro Latsis. Ben Wirz leads the London office, while Alex Spiro Latsis brings a product, design, media, and technology background. The firm does not present a CEO or CTO structure, so the relevant leadership roles are its partners and operating team.

Alongside the Fund III announcement, Brighteye promoted David Guérin to Partner, Isabella Vahdati to Principal, and Rhys Spence to Head of Platform & Research. Those promotions matter because the fund's wider mandate depends on more than capital allocation; it requires research, founder support, customer access, and enough category discipline to connect very different markets without flattening them.

Brighteye was founded in 2017 and operates through teams and entities spanning Luxembourg, London, and Paris. The firm's prior vehicle reached a reported €100M final close in 2023 after announcing a $54M first close in 2020, providing historical context for Fund III without turning different currencies and close states into a misleading comparison.

What Fund III Still Has to Prove

Fund III now has a $72M first-close base and a visible set of initial investments. The unanswered questions are financial and strategic: the final fund size, check-size and reserve model, pace of deployment, ownership goals, and whether the HumanOS frame produces a portfolio whose companies learn from one another rather than merely sharing a vocabulary.

The first close gives Brighteye room to test that proposition across as many as 35 companies. Each investment will make the category more concrete, especially when a founder can show that smarter software expanded human capability inside a school, hospital, workplace, or labor market where the outcome can be measured.